Last reviewed · How we verify

Acetylsalicylic Acid 80 mg

CHU de Quebec-Universite Laval · FDA-approved active Small molecule Quality 5/100

Acetylsalicylic Acid 80 mg is a Small molecule drug developed by CHU de Quebec-Universite Laval. It is currently FDA-approved. Also known as: Asaphen, Aspirin, ASA.

At a glance

Generic nameAcetylsalicylic Acid 80 mg
Also known asAsaphen, Aspirin, ASA
SponsorCHU de Quebec-Universite Laval
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Acetylsalicylic Acid 80 mg

What is Acetylsalicylic Acid 80 mg?

Acetylsalicylic Acid 80 mg is a Small molecule drug developed by CHU de Quebec-Universite Laval.

Who makes Acetylsalicylic Acid 80 mg?

Acetylsalicylic Acid 80 mg is developed and marketed by CHU de Quebec-Universite Laval (see full CHU de Quebec-Universite Laval pipeline at /company/chu-de-quebec-universite-laval).

Is Acetylsalicylic Acid 80 mg also known as anything else?

Acetylsalicylic Acid 80 mg is also known as Asaphen, Aspirin, ASA.

What development phase is Acetylsalicylic Acid 80 mg in?

Acetylsalicylic Acid 80 mg is FDA-approved (marketed).

Related